Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Keybanc Upgrades MKS Instruments to Overweight, Announces $100 Price Target

Keybanc Upgrades MKS Instruments to Overweight, Announces $100 Price Target

Keybanc analyst Steve Barger upgrades MKS Instruments (NASDAQ:MKSI) from Sector Weight to Overweight and announces $100 price target.

byBenzinga Newsdesk

December 20, 2022

1 minute read

Keybanc analyst Steve Barger upgrades MKS Instruments (NASDAQ:MKSI) from Sector Weight to Overweight and announces $100 price target.

Analyst Ratings

BMO Capital Maintains Market Perform Rating for WalkMe: Here’s What You Need To Know

By Benzinga Insights

November 15, 1:00 PM

BMO Capital has decided to maintain its Market Perform rating of WalkMe (NASDAQ:WKME) and raise its price target…

WKME

Analyst Ratings

Where CTI BioPharma Stands With Analysts

By Benzinga Insights

Today, 9:09 AM

Within the last quarter, CTI BioPharma (NASDAQ:CTIC) has observed the following analyst ratings:

CTIC

ECS, ASGN’s Federal Government Segment, Wins $154M IT Ops U.S. Navy Contract

By Happy Mohamed

August 1, 8:22 AM

Company will continue to modernize network transport infrastructure supporting emergency response operations at Navy Installations ECS, a leader in advanced technology, science, and engineering solutions, has won a

ASGN

Analyst Ratings

Analyst Expectations for Procore Technologies’s Future

By Benzinga Insights

July 11, 9:01 AM

Over the past 3 months, 11 analysts have published their opinion on Procore Technologies (NYSE:PCOR) stock. These analysts…

PCOR

Keybanc Upgrades MKS Instruments to Overweight, Announces $100 Price Target

Related Posts

BMO Capital Maintains Market Perform Rating for WalkMe: Here’s What You Need To Know

Where CTI BioPharma Stands With Analysts

ECS, ASGN’s Federal Government Segment, Wins $154M IT Ops U.S. Navy Contract

Analyst Expectations for Procore Technologies’s Future